Drug Development Legislation Targeted For Next Year By Rep. Upton
Executive Summary
Energy and Commerce Committee chairman outlines a plan to develop legislation to accelerate pharmaceutical “discovery, development and delivery.”
You may also be interested in...
NIH And 10 Biopharmas Hatch Plan To Accelerate And Improve Therapeutic Pathway Research
With $230 million from industry and NIH, the Accelerating Medicines Partnership will seek to hasten and improve the success rate for discovery of biomarkers and therapeutic pathways in Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus.
Avastin Loses Its Breast Cancer Claim; FDA’s Hamburg Opts For Withdrawal Over Restrictions
FDA Commissioner Margaret Hamburg says Genentech has failed to identify a subpopulation of patients in whom the clinical benefits outweigh the risks. The company says it will not appeal the indication’s withdrawal but will pursue a new study in breast cancer.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.